Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$191.17 - $325.63 $227,874 - $388,150
1,192 Added 48.3%
3,660 $1.19 Million
Q4 2023

Feb 14, 2024

SELL
$160.99 - $215.69 $10,303 - $13,804
-64 Reduced 2.53%
2,468 $470,000
Q3 2023

Nov 14, 2023

SELL
$194.33 - $283.97 $100,079 - $146,244
-515 Reduced 16.9%
2,532 $504,000
Q2 2023

Aug 14, 2023

BUY
$223.05 - $302.68 $2,676 - $3,632
12 Added 0.4%
3,047 $869,000
Q1 2023

May 15, 2023

BUY
$175.41 - $217.92 $7,542 - $9,370
43 Added 1.44%
3,035 $658,000
Q4 2022

Feb 13, 2023

BUY
$204.38 - $296.82 $49,664 - $72,127
243 Added 8.84%
2,992 $615,000
Q3 2022

Nov 09, 2022

BUY
$195.21 - $310.53 $179,593 - $285,687
920 Added 50.3%
2,749 $764,000
Q2 2022

Aug 12, 2022

BUY
$115.91 - $214.48 $211,999 - $392,283
1,829 New
1,829 $349,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.